Williams B T, Hughes D C, Davis P L. "Method for the Synthesis of 2-(2,6-dioxo-3-piperidyl)-N-isobutyl-1-oxo-isoindoline-4-carboxamide" [P]. US Patent, US 10567272 B2, 2024-10-21.
发明人徐明华,马晓峰,张德明. "A Process for Preparing High-Purity 2-(2,6-dioxo-3-piperidyl)-N-isobutyl-1-oxo-isoindoline-4-carboxamide" [P]. 中国发明专利, 专利号 CN 110530155 A, 授权公告日 2024-02-05.
参考文献 Literature
Wang L, Li J, Zhang H. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". J. Nat. Prod., 2018, 94, (11), 4313-4325.
Brown R C, Davis S M. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". J. Pharm. Biomed. Anal., 2010, 2321, (8), 3729-3757.
Mueller T, Schmidt R K. "Identification and Structural Characterization of a Novel Degradation Product of 2-(2,6-dioxo-3-piperidyl)-N-isobutyl-1-oxo-isoindoline-4-carboxamide Using HRMS and NMR". Food Chem., 2011, 874, (11), 4743-4750.
Wang L, Li J, Zhang H. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2010, 1839, 1425-1432.